Skip to Content

Portrazza Prices, Coupons and Patient Assistance Programs

Portrazza (necitumumab) is a member of the EGFR inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer.

Portrazza Prices

This Portrazza price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Portrazza intravenous solution (16 mg/mL) is around $4,353 for a supply of 50 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

16 mg/mL Portrazza intravenous solution
from $4,353.27 for 50 milliliters
Quantity Per unit Price
50 milliliters $87.07 $4,353.27

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Portrazza Coupons and Rebates

Portrazza offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Portrazza Lilly PatientOne Co-pay Program: Eligible patients may pay no more than $25 per dose with a maximum savings of up to $25,000; for additional information contact the program at 866-472-8663.

Applies to:Portrazza
Number of uses:Per prescription until program expires
ExpiresDecember 31, 2018

Patient Assistance Programs for Portrazza

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Portrazza (necitumumab)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Portrazza (necitumumab)

Provider: Good Days Program

Elligibility requirements:

  1. Not specified
  2. Not disclosed
  3. Not specified
  4. US residency requirements are not specified.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Portrazza (necitumumab)

Provider: PatientOne Oncology

Elligibility requirements:

  1. Must have no prescription coverage for needed medication
  2. At or below 500% of FPL
  3. Must be used for on-label diagnosis
  4. The patient must also be a US resident.
  5. The patient and physician must submit information to PatientOne for a benefits investigation before application will be given for the assistance program. For underinsured patients program helps connect patients with programs that can help them cover the cost of copayments and deductibles. Patients who do not have prescription insurance are reviewed for eligibility into the PatientOne patient Lilly assistance program. Certification of Brand Name Drug Usage Form only needs to be completed for those seeking assistance for Gemzar.

Applicable drugs:

  • Portrazza (necitumumab)
Hide